Fundraising Fox
/Companies
Sign in

CurifyLabs

Helsinki, FI · Founded 2021 · 44 employees on LinkedIn · 4 known investors

Find your way into CurifyLabs

93 people in our graph can introduce you to the CurifyLabs team.

Sign up to see every warm intro you have to CurifyLabs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CurifyLabs team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications. The platform serves hospital and retail pharmacies in Europe and the US, particularly for underserved patient populations including children and cancer patients.

Digital HealthHealthtechMedical Devices

Founders & leadership

CurifyLabs was founded in 2021 by Charlotta Topelius, Niklas Sandler Topelius, and Niklas Sandler.

CTCharlotta Topelius
Charlotta TopeliusCEO & FounderCharlotta Topelius holds a master's degree in Economics and previously worked in a leadership position at a major Nordic corporation. She is co-founder and CEO of CurifyLabs, which develops an automated compounding system for pharmacies that uses robotics and quality control software to prepare customized medications faster and safer than manual processes.
NSNiklas Sandler Topelius
Niklas Sandler Topelius
NSNiklas Sandler
Niklas SandlerCTO & FounderHe spent over a decade as Professor in Pharmaceutics at Åbo Akademi University, where he also served as Vice Rector, and was Chief Technology Officer at Nanoform before co-founding CurifyLabs in 2021. His board roles have included the Sigrid Jusélius Foundation, the Orion Research Foundation, and iPAT - Intelligent Pharmaceutics Ltd.

Investors · 4

Lifeline Ventureslisted by Lifeline VenturesHelsinki

How we know: Lifeline Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

Sandwaterlisted by SandwaterOslo · $2.2M – $11M

How we know: Sandwater's portfolio page · Not right? Tell us

Tesi (Finnish Industry Investment Ltd)reportedHelsinki · $5.4M – $16.2M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$28M disclosed across 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Finland's CurifyLabs raises €12 million to expand 3D printing-based medicine compounding | EU-Startupseu-startups.com · Jul 2026CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicineprnewswire.com · Jul 2026CurifyLabs Raises $14M in Series A Fundingfinsmes.com · Jul 2026CurifyLabs' second raise in 14 months: husband-and-wife startup lands $14M to automate personalised medicine — TFNtechfundingnews.com · Jul 2026

Frequently asked questions

What does CurifyLabs do?
CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications. The platform serves hospital and retail pharmacies in Europe and the US, particularly for underserved patient populations including children and cancer patients.
Who founded CurifyLabs?
CurifyLabs was founded by Charlotta Topelius, Niklas Sandler Topelius, Niklas Sandler in 2021.
Who are CurifyLabs's investors?
CurifyLabs's investors include HealthCap, Lifeline Ventures, Sandwater, Tesi (Finnish Industry Investment Ltd).
How much funding has CurifyLabs raised?
CurifyLabs has disclosed $28M raised across 2 rounds.
Where is CurifyLabs headquartered?
CurifyLabs is headquartered in Helsinki, FI.